RecruitingInterventional · Phase 4NCT03991169 ↗Pilot Pragmatic Clinical Trial of Oral Iron Therapy in Children With Chronic Kidney Disease
RecruitingInterventional · Not applicableNCT06483230 ↗A Pilot Study on Tolerance and Ease of Implementation of Intensive Visual Stimulation (IVS3) in Daily Practice for Upper Limb Motor Recovery in Outpatient Rehab CenterJoan StillingPIInterventionDevice: Intensive Visual Stimulation DeviceDatesOct 2024 – Mar 2027 (est.)SponsorWeill Medical College of Cornell UniversityNeglect, HemispatialStroke, CardiovascularMirror Movement+1 more
RecruitingInterventional · Not applicableNCT06565104 ↗Adding Sleep to the BWell4Life Diet and Physical Activity Intervention for Cardiometabolic Health Promotion: The Sleep2BWell Community-Based TrialErica PhillipsPIInterventionBehavioral: Multidimensional Sleep Health Sessions · Behavioral: Healthy Diet Sessions · Behavioral: Physical Activity SessionsDatesJan 2025 – Jun 2027 (est.)SponsorColumbia UniversityBlood PressureSleep HealthDiet, Healthy+2 more
CompletedInterventional · Phase 2NCT05819359 ↗A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BIA 28-6156 in Subjects With Parkinson's Disease With a Pathogenic Variant in the Glucocerebrosidase (GBA1) GeneHarini SarvaPIInterventionDrug: BIA 28-6156 10 mg · Drug: BIA 28-6156 60 mg · Drug: PlaceboDatesMar 2023 – Apr 2026SponsorBIAL R&D Investments S.A.Parkinson's Disease
CompletedInterventional · Phase 3NCT05822830 ↗A Phase 3b, Randomized Controlled Study to Evaluate the Efficacy and Safety of Tirzepatide Compared to Semaglutide in Adults Who Have Obesity or Overweight With Weight Related ComorbiditiesAlpana P. ShuklaPIInterventionDrug: Tirzepatide · Drug: SemaglutideDatesApr 2023 – Nov 2024· Results postedSponsorEli Lilly and CompanyObesityOverweight